Keyphrases
Neuropathology
100%
Glioblastoma
100%
Newly Diagnosed Glioblastoma
100%
Evidence-based Clinical Practice Guideline
100%
Adult Patients
80%
IDH-wildtype
80%
WHO Grade II
60%
WHO Grade III
60%
Infiltrating Astrocytoma
60%
IDH-mutant Glioma
60%
Genetic Modification
40%
Molecular Genetics
40%
Isocitrate Dehydrogenase 1 (IDH1)
40%
H3K27M
40%
Newly Diagnosed
40%
Accurate Classification
40%
WHO Grade IV
40%
Histological Criteria
40%
Isocitrate Dehydrogenase 1 mutation
40%
Isocitrate dehydrogenase-2 mutation
40%
Infiltrating Glioma
40%
Outcome Prognosis
40%
Sequence Analysis
20%
Immunohistochemistry
20%
Non-canonical
20%
Anatomic Location
20%
Prognosis Prediction
20%
Prognostic Information
20%
Molecular Features
20%
Chromosome 7
20%
Universal Testing
20%
Mutational Status
20%
Chromosome 10
20%
EGFR Amplification
20%
Astrocytoma
20%
Behavior Prediction
20%
Diffuse Astrocytoma
20%
Amplifier Gain
20%
Classification Information
20%
Neuroscience
Astrocytoma
100%
Behavior (Neuroscience)
75%
Histopathology
75%
Isocitrate Dehydrogenase 1
75%
Isocitrate Dehydrogenase 2
75%
Gene Mutation
50%
Chromosome 7
25%
Chromosome 10
25%
Shotgun Sequencing
25%
Immunohistochemistry
25%
Epidermal Growth Factor Receptor
25%
Protein Sequencing
25%
Medicine and Dentistry
Glioblastoma
100%
Neuropathology
100%
Systematic Review
100%
Oligoastrocytoma
40%
Histopathology
30%
Ganglioglioma
30%
Isocitrate Dehydrogenase 1
30%
Isocitrate Dehydrogenase 2
30%
Gene Mutation
20%
Prognostication
20%
Biological Product
10%
Epidermal Growth Factor Receptor
10%
Chromosome 10
10%
Chromosome 7
10%
Immunohistochemistry
10%
Sequence Analysis
10%
Protein Sequencing
10%
Biochemistry, Genetics and Molecular Biology
Isocitrate Dehydrogenase
100%
Molecular Genetics
66%
Gene Mutation
66%
Protein Sequencing
33%
Chromosome 7
33%
Chromosome 10
33%
Shotgun Sequencing
33%
Epidermal Growth Factor Receptor
33%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Astrocytoma
40%
Isocitrate Dehydrogenase 1
30%
Isocitrate Dehydrogenase 2
30%
Biological Product
10%
Epidermal Growth Factor Receptor
10%